Abstract:RING finger proteins (RNFs) play a critical role in cancer initiation and progression. RNF141 is a member of RNFs family; however, its clinical significance, roles, and mechanism in colorectal cancer (CRC) remain poorly understood. Here, we examined the expression of RNF141 in 64 pairs of CRC and adjacent normal tissues by real-time PCR, Western blot, and immunohistochemical analysis. We found that there was more expression of RNF141 in CRC tissue compared with its adjacent normal tissue and high RNF141 expression associated with T stage. In vivo and in vitro functional experiments were conducted and revealed the oncogenic role of RNF141 in CRC. RNF141 knockdown suppressed proliferation, arrested the cell cycle in the G1 phase, inhibited migration, invasion and HUVEC tube formation but promoted apoptosis, whereas RNF141 overexpression exerted the opposite effects in CRC cells. The subcutaneous xenograft models showed that RNF141 knockdown reduced tumor growth, but its overexpression promoted tumor growth. Mechanistically, liquid chromatography-tandem mass spectrometry indicated RNF141 interacted with KRAS, which was confirmed by Co-immunoprecipitation, Immunofluorescence assay. Further analysis with bimolecular fluorescence complementation (BiFC) and Glutathione-S-transferase (GST) pull-down assays showed that RNF141 could directly bind to KRAS. Importantly, the upregulation of RNF141 increased GTP-bound KRAS, but its knockdown resulted in a reduction accordingly. Next, we demonstrated that RNF141 induced KRAS activation via increasing its enrichment on the plasma membrane not altering total KRAS expression, which was facilitated by the interaction with LYPLA1. Moreover, KRAS silencing partially abolished the effect of RNF141 on cell proliferation and apoptosis. In addition, our findings presented that RNF141 functioned as an oncogene by upregulating KRAS activity in a manner of promoting KRAS enrichment on the plasma membrane in CRC.

Retinoic Acid Receptor Α Facilitates Human Colorectal Cancer Progression Via Akt and MMP2 Signaling.

Oncogenic Retinoic Acid Receptor Α Promotes Human Colorectal Cancer Growth Through Simultaneously Regulating P21 Transcription and GSK3β/β-catenin Signaling.

Oncogenic Retinoic Acid Receptor Γ Knockdown Reverses Multi-Drug Resistance of Human Colorectal Cancer Via Wnt/β-catenin Pathway

Retinoic Acid Receptor α Knockdown Suppresses the Tumorigenicity of Esophageal Carcinoma via Wnt/β-catenin Pathway

High Expression of RARβ is a Favorable Factor in Colorectal Cancer

Retinoic Acid Receptor Gamma is Required for Proliferation of Pancreatic Cancer Cells

Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.

Oncogenic Potential Of Retinoic Acid Receptor-Gamma In Hepatocellular Carcinoma

Diverse Ras-related GTPase DIRAS2, downregulated by PSMD2 in a proteasome-mediated way, inhibits colorectal cancer proliferation by blocking NF-B signaling

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

RPL36A activates ERK pathway and promotes colorectal cancer growth

ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway

High Expression of Ras-related Protein 1A Promotes an Aggressive Phenotype in Colorectal Cancer Via PTEN/FOXO3/CCND1 Pathway.

Ribosomal Protein RPS15A Augments Proliferation of Colorectal Cancer RKO Cells Via Regulation of BIRC3, P38 MAPK and Chk1.

Knockdown of PPARδ Induces VEGFA-Mediated Angiogenesis via Interaction With ERO1A in Human Colorectal Cancer

IDDF2020-ABS-0179 Cholesterol-Rorα/Γ Axis Promotes Colorectal Cancer Progression Through C-Myc Stabilization

RRS1 Silencing Suppresses Colorectal Cancer Cell Proliferation and Tumorigenesis by Inhibiting G2/M Progression and Angiogenesis

Data from RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo–Yap Pathway

RARγ-induced E-cadherin Downregulation Promotes Hepatocellular Carcinoma Invasion and Metastasis

RNF141 interacts with KRAS to promote colorectal cancer progression

Elevated Expression of Retinoic Acid Receptor-Alpha (rar Alpha) in Estrogen-Receptor-Positive Breast Carcinomas As Detected by Immunohistochemistry